Brief: AstraZeneca Says Imfinzi Approved In US For Early Bladder Cancer
29/05/2026 07:14
BRIEF-AstraZeneca Says Imfinzi Approved In US For Early Bladder Cancer May 29 (Reuters) - AstraZeneca PLC AZN.L:
ASTRAZENECA PLC - IMFINZI APPROVED IN US FOR EARLY BLADDER CANCER
Further company coverage: AZN.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AstraZeneca
See all newsUK Stocks-Factors to watch on July 10 (updated)
UK Stocks-Factors to watch on July 10
US appeals court upholds win for AstraZeneca in Pfizer cancer drug patent fight (updated)
US appeals court upholds win for AstraZeneca in Pfizer cancer drug patent fight
UK's FTSE 100 ticks lower as AstraZeneca drag offsets banks, mining gains